1. Name and Address of Reporting Person * |
ROSENWALD LINDSAY A MD |
|
2. Date of Event Requiring Statement (Month/Day/Year) 09/13/2011 |
3. Issuer Name and Ticker or Trading Symbol CORONADO BIOSCIENCES INC [NONE]
|
C/O CORONADO BIOSCIENCES, INC., 15 NEW ENGLAND EXECUTIVE PARK |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
__X__ Director |
_____ 10% Owner |
_____ Officer (give title below) |
_____ Other (specify below) |
|
|
5. If Amendment, Date Original Filed(Month/Day/Year)
|
BURLINGTON, MA 01803 |
6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
|
Table I - Non-Derivative Securities Beneficially Owned |
|
1.Title of Security (Instr. 4) |
2. Amount of Securities Beneficially Owned (Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) |
4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Common Stock, par value $.001 per share
|
2,047,632
|
D
|
|
Common Stock, par value $.001 per share
|
40,640
|
I
|
By Capretti Grandi, LLC
|
Common Stock, par value $.001 per share
|
42,676
|
I
|
By LAR Family Trusts
|
Common Stock, par value $.001 per share
|
71,303
|
I
|
By Paramount Biosciences
|
Common Stock, par value $.001 per share
|
100,000
|
I
|
By The Lindsay A. Rosenwald Rhode Island Irrevocable Trust U/T/A DTD 8-28-01
|
Common Stock, par value $.001 per share
|
80,000
|
I
|
By The Lindsay A. Rosenwald Alaska Irrevocable Trust U/T/A DTD 8-29-01
|
Common Stock, par value $.001 per share
|
720,000
|
I
|
By The Lindsay A. Rosenwald 2000 Irrevocable Trust U/T/A DTD 5-24-00
|
Common Stock, par value $.001 per share
|
100,000
|
I
|
By The Lindsay A. Rosenwald Nevada Irrevocable Indenture of Trust U/T/A DTD 8-29-01
|
|
1. Title of Derivative Security (Instr. 4) |
2. Date Exercisable and Expiration Date (Month/Day/Year) |
3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) |
6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable |
Expiration Date |
Title |
Amount or Number of Shares |
Options to purchase Common Stock
|
(1)
|
10/05/2020 |
Common Stock
|
25,000
|
$
1.37
|
D
|
|
Warrant to purchase Common Stock
|
04/26/2010 |
01/22/2014 |
Common Stock
|
17,878
|
$
9.23
|
I
|
By Paramount Biosciences, LLC
|
Warrant to purchase Common Stock
|
04/26/2010 |
05/28/2014 |
Common Stock
|
3,337
|
$
9.23
|
I
|
By Pramount Biosciences, LLC
|
Warrant to purchase Common Stock
|
04/26/2010 |
06/25/2014 |
Common Stock
|
5,960
|
$
9.23
|
I
|
By Paramount Biosciences, LLC
|
Series A Convertible Preferred Stock
|
04/26/2010 |
(2)
|
Common Stock
|
98,164
|
$
5.59
|
D
|
|
Series A Convertible Preferred Stock
|
04/26/2010 |
(2)
|
Common Stock
|
81,280
|
$
5.59
|
I
|
By Capretti Grandi, LLC
|
Series A Convertible Preferred Stock
|
04/26/2010 |
(2)
|
Common Stock
|
142,607
|
$
5.59
|
I
|
By Paramount Biosciences, LLC
|
Series A Convertible Preferred Stock
|
04/26/2010 |
(2)
|
Common Stock
|
85,353
|
$
5.59
|
I
|
By LAR Family Trusts
|
Series B Convertible Preferred Stock
|
01/07/2011 |
(2)
|
Common Stock
|
82,536
|
$
5.59
|
D
|
|
Series B Convertible Preferred Stock
|
01/07/2011 |
(2)
|
Common Stock
|
49,063
|
$
5.59
|
I
|
By Capretti Grandi, LLC
|
Series B Convertible Preferred Stock
|
01/07/2011 |
(2)
|
Common Stock
|
528,951
|
$
5.59
|
I
|
By Paramount Biosciences, LLC
|
Series B Convertible Preferred Stock
|
01/07/2011 |
(2)
|
Common Stock
|
325,793
|
$
5.59
|
I
|
By LAR Family Trusts
|
Series C Convertible Preferred Stock
|
05/31/2011 |
(2)
|
Common Stock
|
214,669
|
$
5.59
|
D
|
|